According to the results of a study recently published in <em>JAMA Oncology,</em> high breast density surpasses other known risk factors for developing breast cancer, including family history of the disease, personal history of benign lesions, and later-in-life childbirth.
Karla Kerlikowske, MD
Karla Kerlikowske, MD
According to the results of a study recently published inJAMA Oncology,high breast density surpasses other known risk factors for developing breast cancer, including family history of the disease, personal history of benign lesions, and later-in-life childbirth.
Researchers at the University of California, San Francisco (UCSF) evaluated risk factors in 202,746 women18,437 of which had varying stages of breast cancer, and 184,309 of which did not have cancer—who were enrolled in the Breast Cancer Surveillance Consortium, which is a national collaborative network of 7 mammography registries.
Overall, 4,747 (89.8%) premenopausal and 12,502 (95.1%) postmenopausal women with breast cancer had at least 1 breast cancer risk factor.
However, breast density was the most prevalent risk factor for both premenopausal and postmenopausal women. Researchers noted that 39.3% of premenopausal and 26.2% of postmenopausal breast cancers could potentially be averted if all women with heterogeneously (more than half of the tissue in the breast is dense) or extremely (dense tissue is present in more than 75% of your breast) dense breasts shifted to scattered fibroglandular (which is mostly fat with a few dense areas) breast density.
After examining these breast cancer cases, the investigators “basically found that the risk factor that explained the development of breast cancer, in the largest number of women, was high breast density,” Karla Kerlikowske, MD, researcher in the department of Medicine and Epidemiology and Biostatistics at UCSF and senior author on the study, said in an interview withOncLive. “Breast density is a common and strong risk factor, so it contributes a lot to the development of breast cancer.”
The study also reinforced the fact that obesity can increase the odds of a woman developing breast cancer. Among postmenopausal women, 22.8% of breast cancers could potentially be averted if all overweight and obese women attained a body mass index of less than 25, noted the authors.
“We can do something about obesity by choosing healthy foods and exercise,” she said. “Breast density is also modifiable. Women who are very high-risk can take tamoxifen. Breast feeding is also thought to lower breast density, and the younger people are when they have their children and the more children they have also lowers breast density.”
Dense breasts make it more difficult for radiologists to see cancer on a mammogram. The American Cancer Society states that dense tissue may mask a mass or tumor because both look white on the mammogram.
Kerlikowske believes that breast density leads to breast cancer because of high cellular content in the breasts, as well as the communication between the epithelial cells and stroma tissue.
She added that physicians and researchers should be using risk prediction models to try to identify women who are at risk of invasive breast cancer.
Common factors associated with breast cancer, such as first-degree family history, a history of benign breast biopsy and delaying childbirth until after age 30, each accounted for less than 10% of cases in the population studied.
Kerlikowske said it is important for women to understand and pay attention to their bodies for any potential risk factors that could be associated with developing breast cancer.
“We found that at least 90% of the women who had breast cancer had at least one of the risk factors we looked at,” she said. “So, I think knowing your risk factors and discussing those with your primary provider, and then use our risk calculator, which includes breast density, to calculate the risk.”
Analyzing ADC Treatment Sequencing in Advanced Breast Cancer
March 15th 2024In the first article of a 2-part series, Virginia G. Kaklamani, MD, discussed her approach to biomarker testing and treatment sequencing for patients with hormone receptor–positive, HER2-negative metastatic breast cancer.
Read More
Uncovering the Neighborhood Influence on Breast Cancer Mortality
March 8th 2024Samilia Obeng-Gyasi, MD, MPH, delved into the background and findings of this study assessing the correlation between neighborhood opportunity, allostatic load, and all-cause mortality among patients with breast cancer.
Read More